Skip to content
GLP-1 Savers
Menu
Ranked #294 · Watch List

Signos review

Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $199/mo

Save ~85% vs brand-name

From $199/mo (starting dose, compounded)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose, it is tied to a longer commitment rather than month-to-month billing.

How much does Signos cost?

The price Signos publishes is From $199/mo (starting dose, compounded). We flag this one to watch: confirm the ongoing rate with Signos before you count on it, because a low first month can step up afterward. That works out about 85% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $199/mo (6-month plan, compounded)
Tirzepatide
From $199/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Signos scored on our six published factors. See the methodology.

Lowest Real Price72/100
No Teaser-Rate Bait54/100
Nationwide Availability45/100
Both Molecules92/100
Easy Cancellation62/100
Reputation78/100

Why it's a deal

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Read the fine print

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

The bottom line

Best for: Shoppers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app. Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app.

Ranked #294 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Signos, out of 426 others we track.

Shopping Signos against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Signos, and every program that undercuts or outscores it — starting with MyStart Health, the closest match on score — is ranked on the Signos alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Signos's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Signos's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals